Keyphrases
COVID-19
100%
Candidiasis
100%
Emerging Concern
100%
Candida Auris
100%
Patients with COVID-19
60%
Aurès
60%
Critically Ill Patients
40%
Multidrug-resistant
40%
Echinocandins
40%
Epidemiology
20%
High Risk
20%
Therapeutic Strategies
20%
Candida Albicans (C. albicans)
20%
Low Risk
20%
Increased Incidence
20%
Antifungal Agents
20%
Novel Therapeutics
20%
Graves
20%
Candida Tropicalis
20%
Whole Genome Sequencing
20%
Fluconazole
20%
First-line Therapy
20%
Candida Glabrata
20%
Candida Species
20%
Fluconazole Resistance
20%
Azoles
20%
Candidemia
20%
Healthcare-associated
20%
Hospitalized Patients
20%
Drug Choice
20%
Pandemic Period
20%
Pre-pandemic
20%
Azole Resistance
20%
Infection Prevention Policies
20%
COVID-19 Incidence
20%
Regular Screening
20%
Infection Control Policies
20%
Pharmacology, Toxicology and Pharmaceutical Science
Infection
100%
Candidiasis
100%
Candida Auris
100%
Fluconazole
40%
Pyrrole
40%
Candida Albicans
20%
Candida
20%
Antifungal Agent
20%
Candida Tropicalis
20%
Candidemia
20%
Candida Glabrata
20%